Adlai Nortye 集团
ANL
11.03
-1.06
-8.77%
Adlai Nortye 集团
US · ANL
#3309 按市值排名
上市于 2023
11.03
-1.06
-8.77%
实时 - 追踪5344个代码 - 心跳于21秒前
· 2026-10-16 20:02
✦ 量化股权信号 计算方式说明
增持
- 最近一期（2026/Q3）披露持股的机构数量增加了2家。
- 机构持股总比例上升了0.1个百分点。
机构持股
- 机构持股比例
- 68.30% +0.12pp
- 机构数量
- 50 +2
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向一致机构在上一报告期增持了股份，同时该股在最近20个交易日的主力资金呈净流入——两者方向一致。
机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。
持股人类型
Hedge Fund25.38%
Corporate Pension Plan16.47%
VC/PE Fund13.93%
Private Company7.84%
Mutual Fund4.66%
Individual/Insider0.93%
Other30.77%
主要股东 截至 2026-03-18
Nortye International Limited , ESOP
16.47% · 10.60M 股
Cormorant Asset Management, LP
6.18% · 3.98M 股
VR Management, LLC
4.99% · 3.21M 股
Trident Trust Group
4.81% · 3.10M 股
Balyasny Asset Management L.P.
4.75% · 3.06M 股
Point72 Asset Management, L.P.
3.32% · 2.14M 股
MPM BioImpact LLC
3.01% · 1.94M 股
ICBC Credit Suisse Asset Management Co., Ltd.
2.98% · 1.92M 股
Perceptive Advisors LLC
2.78% · 1.79M 股
Boary Investment Co. Ltd.
2.75% · 1.77M 股
条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。
内部人持股
共追踪16份申报 · 1次买入 · 5次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Nortye International Limited , ESOP | -- | 16.47% |
| Lars Erik Birgerson | Director | 0.26% |
| Xiaofeng Ye | Interim CFO and VP of Business Development & Commercialization Strategy | 0.23% |
| Ping Ji | Director | 0.19% |
| Yang Lu | Chairperson & CEO | 0.16% |
| Ngai Chiu Tse | Head of Research & Development | 0.08% |
| Roger Sawhney | Director | 0.02% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-29 | Ping Ji | Director | Open Market Disposition | -10,214 | $15.77–16.03 |
| 2026-09-28 | Ping Ji | Director | Intent to Sell (Form 144) | -80,000 | $15.28 |
| 2026-09-21 | Ping Ji | Director | Open Market Disposition | -5,000 | $16.63 |
| 2026-08-25 | Xiaofeng Ye | Interim CFO and VP of Business Development & Commercialization Strategy | Open Market Disposition | -11,667 | $13.98–14.25 |
| 2026-06-09 | Ping Ji | Director | Other Acquisition | +136,667 | -- |
| 2026-05-27 | Xiaofeng Ye | Interim CFO and VP of Business Development & Commercialization Strategy | Initial Statement of Beneficial | 0 | -- |
| 2026-05-12 | Yang Lu | Chairperson & CEO | Open Market Disposition | -10 | $13.18 |
| 2026-03-17 | Roger Sawhney | Director | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Ngai Chiu Tse | Head of Research & Development | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Lars Erik Birgerson | Director | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Yang Lu | Chairperson & CEO | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Nortye International Limited , ESOP | -- | Initial Statement of Beneficial | 0 | -- |
Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 20:02:32 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
Adlai Nortye 集团 讨论区 0 条评论